Physician profile
Christopher E Kennel
NPI 1922480698
$2,062.90
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,983 · 2020: $35.62 · 2021: $44.65.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,402.34 | 2019-2020 | |
| Medical Device Business Services, INC. | $239.99 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $167.27 | 2019 | |
| Alk-Abello, INC | $96.20 | 2019 | |
| Glaxosmithkline, LLC. | $46.00 | 2019 | |
| Advanced Bionics, LLC | $44.65 | 2021 | |
| Novartis Pharmaceuticals Corporation | $27.85 | 2019 | |
| Intersect Ent, INC. | $26.75 | 2019 | |
| Biocryst Pharmaceuticals, INC. | $11.85 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Kennel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.